In Situ Vaccine for Low-Grade Lymphoma: Combination of Intratumoral Flt3L and Poly-ICLC With Low-Dose Radiotherapy
Clinical trial NCT01976585 · COMPLETED
Trial details
- NCT number
- NCT01976585
- Sponsor
- Joshua Brody
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-03
- Primary completion
- 2020-11-20
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.